Richard C. Bates

5.1k total citations · 1 hit paper
51 papers, 4.3k citations indexed

About

Richard C. Bates is a scholar working on Molecular Biology, Immunology and Allergy and Oncology. According to data from OpenAlex, Richard C. Bates has authored 51 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 15 papers in Immunology and Allergy and 14 papers in Oncology. Recurrent topics in Richard C. Bates's work include Cell Adhesion Molecules Research (15 papers), Cancer Cells and Metastasis (11 papers) and Heat shock proteins research (11 papers). Richard C. Bates is often cited by papers focused on Cell Adhesion Molecules Research (15 papers), Cancer Cells and Metastasis (11 papers) and Heat shock proteins research (11 papers). Richard C. Bates collaborates with scholars based in United States, Australia and Japan. Richard C. Bates's co-authors include Arthur M. Mercurio, Gordon F. Burns, David A. Proia, David I. Bellovin, Kathleen N. Moore, Michael J. Birrer, Ilaria Betella, Peter Oettgen, Courtney Brown and Michael Agrez and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Cell Biology.

In The Last Decade

Richard C. Bates

51 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibody-Drug Conjugate-Based Therapeutics: State of the Science

2019 323 citations Richard C. Bates et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard C. Bates United States	32	2.2k	1.6k	739	568	566	51	4.3k
Mina Fogel Israel	31	2.1k 1.0×	1.3k 0.8×	464 0.6×	853 1.5×	876 1.5×	62	3.9k
Philip J. Gotwals United States	28	1.8k 0.8×	1.1k 0.7×	893 1.2×	1.1k 2.0×	595 1.1×	37	4.4k
Gary D. Shipley United States	32	3.2k 1.5×	1.5k 0.9×	609 0.8×	578 1.0×	719 1.3×	48	5.8k
Alexander Berndt Germany	35	1.7k 0.8×	1.3k 0.9×	891 1.2×	722 1.3×	656 1.2×	137	4.1k
Armando Bartolazzi Italy	35	2.0k 0.9×	1.1k 0.7×	541 0.7×	974 1.7×	460 0.8×	115	4.1k
George P. Tuszynski United States	44	3.1k 1.5×	804 0.5×	868 1.2×	549 1.0×	1.4k 2.5×	104	4.9k
Gordon Parry United States	22	1.6k 0.8×	790 0.5×	473 0.6×	581 1.0×	337 0.6×	49	3.5k
D. J. Ruiter Netherlands	45	2.8k 1.3×	2.2k 1.4×	1.0k 1.4×	1.5k 2.6×	1.1k 1.9×	128	6.2k
Andries Zijlstra United States	38	2.7k 1.2×	1.1k 0.7×	645 0.9×	600 1.1×	1.3k 2.3×	84	4.6k
Shuan Shian Huang United States	35	2.4k 1.1×	669 0.4×	353 0.5×	323 0.6×	676 1.2×	75	3.9k

Countries citing papers authored by Richard C. Bates

Since Specialization

Citations

This map shows the geographic impact of Richard C. Bates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard C. Bates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard C. Bates more than expected).

Fields of papers citing papers by Richard C. Bates

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard C. Bates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard C. Bates. The network helps show where Richard C. Bates may publish in the future.

Co-authorship network of co-authors of Richard C. Bates

This figure shows the co-authorship network connecting the top 25 collaborators of Richard C. Bates. A scholar is included among the top collaborators of Richard C. Bates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard C. Bates. Richard C. Bates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Groves, Carol L., et al.. (2020). First Report of Bacterial Leaf Streak of Corn Caused by Xanthomonas vasicola pv. vasculorum in Wisconsin. Plant Disease. 104(11). 3055–3055. 1 indexed citations

Proia, David A., Donald L. Smith, Junyi Zhang, et al.. (2015). HSP90 Inhibitor–SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors. Molecular Cancer Therapeutics. 14(11). 2422–2432. 29 indexed citations

Acquaviva, Jaime, Donald L. Smith, John-Paul Jimenez, et al.. (2014). Overcoming Acquired BRAF Inhibitor Resistance in Melanoma via Targeted Inhibition of Hsp90 with Ganetespib. Molecular Cancer Therapeutics. 13(2). 353–363. 79 indexed citations

Acquaviva, Jaime, Suqin He, Chaohua Zhang, et al.. (2014). FGFR3 Translocations in Bladder Cancer: Differential Sensitivity to HSP90 Inhibition Based on Drug Metabolism. Molecular Cancer Research. 12(7). 1042–1054. 57 indexed citations

Acquaviva, Jaime, Suqin He, Jim Sang, et al.. (2014). mTOR Inhibition Potentiates HSP90 Inhibitor Activity via Cessation of HSP Synthesis. Molecular Cancer Research. 12(5). 703–713. 40 indexed citations

Sang, Jim, Jaime Acquaviva, Julie C. Friedland, et al.. (2013). Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer. Cancer Discovery. 3(4). 430–443. 174 indexed citations

Proia, David A., Chaohua Zhang, Manuel Sequeira, et al.. (2013). Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer. Clinical Cancer Research. 20(2). 413–424. 53 indexed citations

Zhou, Dan, Yuan Liu, Weiwen Ying, et al.. (2013). A rat retinal damage model predicts for potential clinical visual disturbances induced by Hsp90 inhibitors. Toxicology and Applied Pharmacology. 273(2). 401–409. 56 indexed citations

Bates, Richard C., Bryan Pursell, & Arthur M. Mercurio. (2007). Epithelial-Mesenchymal Transition and Colorectal Cancer: Gaining Insights into Tumor Progression Using LIM 1863 Cells. Cells Tissues Organs. 185(1-3). 29–39. 41 indexed citations

10.

Bates, Richard C., David I. Bellovin, Courtney Brown, et al.. (2005). Transcriptional activation of integrin β6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. Journal of Clinical Investigation. 115(2). 339–347. 291 indexed citations

11.

Bates, Richard C. & Arthur M. Mercurio. (2005). The epithelial-mesenchymal tansition (EMT) and colorectal cancer progression. Cancer Biology & Therapy. 4(4). 371–376. 246 indexed citations

12.

Bates, Richard C.. (2005). Colorectal Cancer Progression: Integrin alphavbeta6 and the Epithelial-Mesenchymal Transition (EMT). Cell Cycle. 4(10). 1350–1352. 73 indexed citations

13.

Mercurio, Arthur M., Robin E. Bachelder, Richard C. Bates, & Jun Chung. (2004). Autocrine signaling in carcinoma: VEGF and the α6β4 integrin. Seminars in Cancer Biology. 14(2). 115–122. 58 indexed citations

14.

Bates, Richard C., Michael DeLeo, & Arthur M. Mercurio. (2004). The epithelial–mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis. Experimental Cell Research. 299(2). 315–324. 113 indexed citations

15.

Bates, Richard C., Jeffrey D. Goldsmith, Robin E. Bachelder, et al.. (2003). Flt-1-Dependent Survival Characterizes the Epithelial-Mesenchymal Transition of Colonic Organoids. Current Biology. 13(19). 1721–1727. 100 indexed citations

16.

Bates, Richard C., et al.. (1998). Engagement of Variant CD44 Confers Resistance to Anti-Integrin Antibody-Mediated Apoptosis in a Colon Carcinoma Cell Line. Cell adhesion and communications/Cell adhesion and communication/Cell adhesion & communication. 6(1). 21–38. 24 indexed citations

17.

Bates, Richard C., et al.. (1996). Factor H co-purifies with thrombospondin isolated from platelet secretate. Biochimica et Biophysica Acta (BBA) - General Subjects. 1289(3). 305–311. 15 indexed citations

18.

Bates, Richard C., Lisa F. Lincz, & Gordon F. Burns. (1995). Involvement of integrins in cell survival. Cancer and Metastasis Reviews. 14(3). 191–203. 85 indexed citations

19.

Agrez, Michael & Richard C. Bates. (1994). Colorectal cancer and the integrin family of cell adhesion receptors: Current status and future directions. European Journal of Cancer. 30(14). 2166–2170. 29 indexed citations

20.

Stomski, Frank C., Jon Gani, Richard C. Bates, & Gordon F. Burns. (1992). Adhesion to thrombospondin by human embryonic fibroblasts is mediated by multiple receptors and includes a role for glycoprotein 88 (CD36). Experimental Cell Research. 198(1). 85–92. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact